Nickols, Nicholas G.
Nazarian, Ramin
Zhao, Shuang G.
Tan, Victor
Uzunangelov, Vladislav
Xia, Zheng
Baertsch, Robert
Neeman, Elad
Gao, Allen C.
Thomas, George V.
Howard, Lauren
De Hoedt, Amanda M.
Stuart, Josh
Goldstein, Theodore
Chi, Kim
Gleave, Martin E.
Graff, Julie N.
Beer, Tomasz M. http://orcid.org/0000-0001-5600-9993
Drake, Justin M.
Evans, Christopher P.
Aggarwal, Rahul
Foye, Adam
Feng, Felix Y.
Small, Eric J.
Aronson, William J.
Freedland, Stephen J.
Witte, Owen N.
Huang, Jiaoti
Alumkal, Joshi J.
Reiter, Robert E.
Rettig, Matthew B.
Funding for this research was provided by:
Stand Up To Cancer Prostate Cancer Dream Team Award SU2C-AACR-DT0812 Prostate Cancer Foundation Challenge Grants
Prostate Cancer Foundation
Prostate Cancer Foundation Young Investigator Awards
EIF | Stand Up To Cancer (SU2C-AACR-DT0812)
Article History
Received: 20 December 2018
Revised: 29 January 2019
Accepted: 1 February 2019
First Online: 25 February 2019
Compliance with ethical standards
:
: NGN's research work has been funded by Janssen, Varian and Bayer. He owns stock options and has consulted for Gene Sciences Inc. MBR’s research has been funded by Novartis. He has been a speaker and consultant for Johnson and Johnson. GWT's work has been funded by the NIH. He has been on the scientific advisory board of Auron Therapeutics. EJS owns stocks in Fortis Therapeutics and Harpoon Therapeutics. He has received honoraria for speaking engagements at Janssen. He is a consultant and on Advisory Board (Compensated) of Janssen and Fortis. FYF receives research funding from Zenith Epigenetics and has received compensation as a member of the scientific advisory board or as a consultant for Bayer, Blue Earth Diagnostics, Celgene, Dendreon, EMD Serono, Ferring, Janssen Oncology, Medivation/Astellas, and Sanofi. He is a co-founder of PFS Genomics and has ownership interests. ONW currently has consulting, equity, and/or board relationships with Trethera Corporation, Kronos Biosciences, Sofie Biosciences, and Allogene Therapeutics. None of these companies contributed to or directed any of the research reported in this article. SGZ has received travel expenses, and has patents filed on unrelated work with GenomeDx Biosciences. The remaining authors declare that they have no conflict of interest.